Original research article| Volume 70, ISSUE 6, P483-486, December 2004

Acceptability of levonorgestrel subdermal implants versus tubal ligation for long-term contraception in a rural population of Zimbabwe


      This prospective cohort study of 257 rural Zimbabwean women was designed to compare patient satisfaction with levonorgestrel subdermal implants (Norplant and reg;) versus tubal ligation (TL) as a method of long-term contraception. Women were equally satisfied with both methods. At 1 year, 96% of Norplant users and 97% of the TL group reported being ���satisfied��� or ���very satisfied,��� and 98% of Norplant users, and 99% of the TL cohort would recommend their chosen method to a friend or relative. Rating scores at both 6 months and 1 year were high and equal, with women in each cohort rating their method, on average, as 9 out of 10. Norplant users were significantly more likely to rate birth spacing as a reason for satisfaction with their method, whereas women in the TL cohort were more likely to select multiparity. The 1-year continuation rate with Norplant was 90%, with 4% discontinuing in order to have more children. Selecting the most appropriate method depends primarily on the potential desire of the woman to have more children.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Contraception
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Meirik O.
        • Farley T.M.
        • Sivin I.
        • Diaz S.
        Post-marketing surveillance of Norplant contraceptive implants: I. Contraceptive efficacy and reproductive health. International collaborative post-marking surveillance of Norplant.
        Contraception. 2001; 63: 167-186
        • Meirik O.
        • Farley T.M.
        • Sivin I.
        • Diaz S.
        • Collins J.
        Post-marketing surveillance of norplant contraceptive implants: II. non-reproductive health. International collaborative post-marketing surveillance of Norplant.
        Contraception. 2001; 63: 187-209
        • Hannaford P.
        Postmarketing surveillance study of Norplant in developing countries.
        Lancet. 2001; 357: 1815-1816
        • Argina H.
        • Lukman H.Y.
        Norplant implants in Ethiopia.
        E. Afri. Med. J. 1997; 74: 258-262
        • Cravioto M.C.
        • Alvarado G.
        • Canto-de-Cetina T.
        • et al.
        A multicenter comparative study on the efficacy, safety, and acceptability of the contraceptive subdermal implants Norplant and Norplant-II.
        Contraception. 1997; 55: 359-367